Next-generation sequencing-guided molecular-targeted therapy and immunotherapy for biliary tract cancers

Autor: Yingying Wang, Junping Shi, Hongyuan Zhou, Ti Zhang, Yan Ke, QiangLi, Wei Zhang, Bo Yang, Zewu Zhang, Zhiqiang Han, Tianqiang Song, Guanghao Li, Guangtai Cao
Rok vydání: 2020
Předmět:
Zdroj: Cancer Immunology, Immunotherapy. 70:1001-1014
ISSN: 1432-0851
0340-7004
Popis: Chemotherapy is a standard regimen for advanced or relapsed biliary tract cancer (BTC) with a 5-year overall survival (OS) rate of approximately 5% and a median OS of less than a year. Targeted therapies and immunotherapy aimed at providing more personalized treatments for BTCs have been tested. The objective of this study was to evaluate the effects of targeted therapy and immunotherapy on advanced BTC patients. Twenty-four advanced/relapsed BTC patients were enrolled and examined with next-generation sequencing (NGS). Eight of them received NGS-guided targeted or immunotherapy, and the other 16 patients underwent routine chemotherapy. Comparison analysis of OS and objective response rate (ORR) was performed. IDH1, BRCA2, MAP2K1, and BRAF (V600E) were the major actionable genes mutated in this cohort. Patients who received NGS-guided therapy exhibited higher OS (not achieved vs. 6.5 months, p
Databáze: OpenAIRE